mVISE — Growth strategy 2.0

mVISE (DB: C1VX)

Last close As at 21/12/2024

1.58

0.01 (0.64%)

Market capitalisation

14m

More on this equity

Research: TMT

mVISE — Growth strategy 2.0

Following a disappointing FY20, mVISE is planning to reinvigorate its growth via acquisition. A small (€1.9m) capital increase has already been undertaken but a further (much larger) raising is expected and consequently the company has delayed its AGM. The financial performance of the core professional services businesses appears to have stabilised in 2021 so far and there are some signs of progress in products also. Consensus forecasts imply a 10% organic revenue growth and EBITDA margin in FY22 and an FY22e EV/EBITDA multiple of 13.0x.

Analyst avatar placeholder

Written by

TMT

mVISE

FY20: H2 deterioration offsets robust H1 performance

Software & comp services

Scale research report - Update

13 July 2021

Price

€2.01

Market cap

€20m

Share price graph

Share details

Code

C1VX

Listing

Deutsche Börse Scale

Shares in issue (including recent capital increase)

9.8m

Last reported net debt as at 31 Dec 2020

€10.2m

Business description

mVISE’s core competencies are IT infrastructures and integration, combined with data management and analytics. With 130 FTE staff, mVISE supports digitisation projects and offers cloud products such as integration platforms-as-a-service elastic.io and SaleSphere.

Bull

Well placed to benefit from digital revolution with orientation to the Internet of Things, digitalisation, integration, data science and security.

Strategy to reinvigorate growth via M&A.

Growth in software products can boost margins and earnings growth.

Bear

M&A strategy creates additional execution risks.

Own-developed software products (elastic.io and SaleSphere) have not achieved expectations.

Net debt is currently €10.2m, 34% of EV.

Analyst

Dan Gardiner

+44 (0)20 3077 5700

Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.

Growth strategy 2.0

Following a disappointing FY20, mVISE is planning to reinvigorate its growth via acquisition. A small (€1.9m) capital increase has already been undertaken but a further (much larger) raising is expected and consequently the company has delayed its AGM. The financial performance of the core professional services businesses appears to have stabilised in 2021 so far and there are some signs of progress in products also. Consensus forecasts imply a 10% organic revenue growth and EBITDA margin in FY22 and an FY22e EV/EBITDA multiple of 13.0x.

A weak 2020, stabilisation in FY21

Reported results (29 June) highlighted that financial performance deteriorated significantly in H220 following a robust start to the year. FY20 revenue fell 11.8% yo-y (including a 26% y-o-y decline in H2) and EBITDA turned negative (loss of €1.0m in FY20 vs earnings of €1.4m in FY19). However, the performance appears to have stabilised in FY21 due to the generally improving macro environment and action by management to cut costs. Management indicates that H121 has seen high levels of utilisation and the business has been EBITDA positive.

Shifting to an M&A driven growth strategy

More significantly, with product growth continuing to underwhelm, in June mVISE announced ‘Growth 21/22’, a new growth strategy primarily driven by acquisition. It is currently evaluating two potential targets, both of which are larger than itself, with the aim of acquiring one. The company has indicated that either would create a combined entity with c €50m of annual sales post consolidation. It believes this entity would enhance its profile and create synergies that would substantially improve profitability. mVISE is looking to fund the acquisition with an equity raise and has delayed the AGM to enable shareholders to approve the deal.

Valuation: M&A prospects likely to drive share price

mVISE is understandably not providing further details about these potential targets at this point, and without these details it is difficult to comment on the likely success of its new strategy. Given the significant size of the pending deal, the prospects for value creation through acquisition are likely to largely drive share price performance over the next few months at least in our view. At €2.01, its share price (including €11.4m of net debt) implies an FY22e EV/EBITDA multiple of 13.0x based on consensus forecasts, an 8% premium to the average of larger IT services peers. These forecasts imply organic revenue growth and an EBITDA margin of 10% in FY22 (compared to 8% and 17% respectively for larger IT services peers).

Consensus estimates

Year
end

Revenue
(€m)

EBITDA
(€m)

EBIT
(€)

EPS
(€)

EV/EBITDA
(x)

EV/EBIT
(x)

P/E
(x)

12/19

21.5

1.4

0.1

(0.03)

21.4

299.7

N/A

12/20

19.0

(1.0)

(2.9)

(0.33)

N/A

N/A

N/A

12/21e

21.9

1.5

(0.1)

(0.05)

20.0

N/A

N/A

12/22e

24.0

2.3

0.8

0.04

13.0

37.5

50.3

Source: Company data, Refinitiv (based on one estimate)

In our note Resilient in the downturn, we highlighted the strong performance of mVISE’s professional service businesses in H1 in the face of COVID-19 restrictions. Unfortunately, this resilience did not continue into H2. After a record Q1, the impact of lower orders and project cancellations prompted by the onset of COVID-19 began to feed into low utilisation, resulting in yearonyear professional services growth falling from 5.6% in H1 to -20.6% in H2. Product sales did improve sequentially (from €0.3m in H1 to €0.5m in H2) but were still down year-on-year and insufficient to make up the shortfall in service revenue. Revenue for year fell by 11.8% (to €19.0m).

As a result of the revenue shortfall, losses increased. The company reported an EBITDA loss of €1.0m for FY20 (vs positive €1.4m in FY19), implying a -15% margin in H2. Amortisation of intangibles of €1.8m (including a €0.4m write-down for SaleSphere) resulted in a reported net loss for FY20 of €4.1m (FY19 loss: €0.3m). Free cash flow (operating cash flow – capex) of €0.2m was boosted by a €3.3m working capital inflow. Net debt rose to €10.2m.

In Q420, management acted to improve the financial performance. Personnel costs, largely in product development at elastic.io, were reduced by €0.8m (9.3%) and other operating expenses were cut by €0.8m (20.1%). The total reduction of annualised costs of €1.6m represents 8% of sales. A new sales director, Arnaud Becuwe, started in April 2021 with the aim of more deeply integrating the sales activities of the product and service businesses.

Improvement in trading and profitability in FY21 (so far)

The financial performance appears to have improved substantially in FY21. mVISE indicates the professional service business was at nearly full utilisation in Q1 and utilisation has remained high into Q2. In addition, elastic.io has secured three new white-label customers: Infobip, Mambu and Tata Consulting. As a result of the improved revenue and the cost reduction measures taken in Q420, mVISE was EBITDA profitable in Q1 and expects to report positive EBITDA in H1.

Growth strategy 2.0

mVISE has a track record of strong revenue growth historically. Between 2014 and 2018, sales grew from €1.8m to €22.5m (a 90% CAGR). In March 2018 it set out its 2018+ Strategy designed to sustain this rapid growth (it targeted sales of €33–35m in 2020, a 33% CAGR) fuelled predominantly by its investments in high-margin elastic.io and SaleSphere software products. mVISE continues to believe these products will grow and both are profitable; however, with combined sales of just €0.8m in FY20, performance has clearly fallen well below its original expectations.

Consequently, mVISE is now looking at a new strategy to sustain its growth. In June it adopted a ‘Growth 2021/22’ strategy designed to ‘accelerate the growth… through integration or merger with a value-creating acquisition in the second half of 2021, thereby expanding the strategic positioning…and achieving significant earnings growth.’

The company has indicated that it is currently evaluating two potential acquisition targets and is looking to acquire one. Both are larger (in value) than itself and would more than double its current revenue base to c €50m. According to the company, consolidation with either would raise mVISE’s profile and lead to synergies that would substantially improve the profitability of the combined entity.

mVISE is looking to fund these acquisitions at least in part by raising equity. In June, following the announcement of the new strategy, the company also issued an additional 0.9m shares (10% of the existing share count, the maximum number of new shares that can be issued under existing authorisations) at €2.1 per share raising €1.9m (gross). Due to the impending transaction the company postponed the 2021 AGM so that it can be held after the terms of the acquisition are established, thus giving investors the opportunity to approve the transaction.

Ahead of any transaction, mVISE is understandably not providing any further details about these potential targets and without these details it is difficult to comment on the likely success of its new strategy. However, making some relatively simple assumptions, it is possible to estimate how much mVISE may have to invest in this strategy. A combined revenue base of over €50m implies the acquisition is generating at least €30m in annual revenues. Assuming a 10% EBITDA margin, consistent with mVISE’s historical (pre 2020) average and the bottom of the professional services peer group range (10–18%), suggests an average business of this size may generate c €3m in EBITDA. Applying a 13x FY21 multiple to this figure, in line with large professional consulting peers and mVISE’s own current FY22 multiple, implies a €39m enterprise valuation (EV). A 10x multiple, arguably more appropriate to smaller peers, would suggest a €30m valuation. Compared to mVISE’s existing €30m enterprise valuation, both figures potentially suggest a substantial capital raising.

We believe the prospects for value creation from this deal are likely to largely drive mVISE’s share price performance over the next few months. The question is whether the potential synergies from the combination will create upside to mVISE’s current share price and justify the execution risks.


.

General disclaimer and copyright

Any Information, data, analysis and opinions contained in this report do not constitute investment advice by Deutsche Börse AG or the Frankfurter Wertpapierbörse. Any investment decision should be solely based on a securities offering document or another document containing all information required to make such an investment decision, including risk factors. This report has been commissioned by Deutsche Börse AG and prepared and issued by Edison for publication globally.

Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2021 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on mVISE

View All

Latest from the TMT sector

View All TMT content

Research: Real Estate

Impact Healthcare REIT — Attractive financial and social returns

Impact Healthcare REIT continues to deliver consistently positive returns, demonstrating the resilience of its tenant operators and the group’s strategy during the pandemic. Accretive portfolio growth combined with long-term inflation-linked rents are driving income and capital growth, while continuing full rent collection underpins increasing dividends.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free